Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Top Smart Score Stocks

STOCKS

Research Tools

Most Visited Websites

Daily Feeds

Daily Analyst Ratings

Daily Insider Trading Tracker

Calendars

Economic Indicators

Economic Indicators Center

Inflation Rate

Unemployment Rate

Federal Funds Rate

Class Actions

Calculators

Dividend Calculator

Dividend Yield Calculator

Options Profit Calculator

Dollar Cost Averaging

Technical Analysis Screener

Dividend Center

Best Dividend Stocks

Popular

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Chemocentryx Inc. (CCXI)

NASDAQ:CCXI

CCXI

ChemoCentryx

RESEARCH TOOLS

Top Smart Score Stocks

Stock Screener

reports

Holding CCXI?

Track your performance easily

Link Broker

ChemoCentryx (CCXI) Stock News & Sentiment

0 Followers

AMGEN SUCCESSFULLY COMPLETES ACQUISITION OF CHEMOCENTRYX

Premium

Press Releases

AMGEN SUCCESSFULLY COMPLETES ACQUISITION OF CHEMOCENTRYX

2y ago

AMGN

CCXI

ChemoCentryx Announces Presentations at the 2022 American Society of Nephrology and American College of Rheumatology Annual Meetings

Premium

Press Releases

ChemoCentryx Announces Presentations at the 2022 American Society of Nephrology and American College of Rheumatology Annual Meetings

2y ago

CCXI

ChemoCentryx Announces Upcoming Presentations for Orally Administered PD-L1 Inhibitor, CCX559, at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Premium

Press Releases

ChemoCentryx Announces Upcoming Presentations for Orally Administered PD-L1 Inhibitor, CCX559, at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting

2y ago

CCXI

ChemoCentryx Announces TAVNEOS® (avacopan) Presentations at Upcoming Medical Conferences

Premium

Press Releases

ChemoCentryx Announces TAVNEOS® (avacopan) Presentations at Upcoming Medical Conferences

2y ago

CCXI

ChemoCentryx Cancels Second Quarter 2022 Financial Results Conference Call

Premium

Press Releases

ChemoCentryx Cancels Second Quarter 2022 Financial Results Conference Call

2y ago

CCXI

AMGEN TO ACQUIRE CHEMOCENTRYX FOR $4 BILLION IN CASH

Premium

Press Releases

AMGEN TO ACQUIRE CHEMOCENTRYX FOR $4 BILLION IN CASH

2y ago

AMGN

CCXI

Can ChemoCentryx Control Challenging Capital Complications?

Premium

Stock Analysis & Ideas

Can ChemoCentryx Control Challenging Capital Complications?

3y ago

CCXI

More CCXI News >

CCXI News on the Web

2022-10-27

Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Zacks

Neutral

2022-10-20

AMGEN SUCCESSFULLY COMPLETES ACQUISITION OF CHEMOCENTRYX

Yahoo Finance

Neutral

2022-10-17

Is ChemoCentryx Inc (CCXI) a Good Buy in the Healthcare Sector?

Investors Observer

Neutral

2022-10-17

ChemoCentryx Announces Presentations at the 2022 American Society of Nephrology and American College of Rheumatology Annual Meetings

Yahoo Finance

Neutral

2022-10-12

Biotech Stocks Well-Positioned For The Fourth Quarter

TalkMarkets

Neutral

2022-10-06

Is ChemoCentryx (CCXI) Stock Outpacing Its Medical Peers This Year?

Zacks

Neutral

2022-10-06

Is ChemoCentryx Stock Outpacing Its Medical Peers This Year?

Yahoo Finance

Neutral

2022-10-05

Is ChemoCentryx Inc (CCXI) a Good Buy in the Biotechnology Industry?

Investors Observer

Neutral

News Score - Last 7 Days

Neutral

CCXI

Sector Average

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CCXI’s Media Buzz Sentiment?

Currently, no data Available

What is CCXI’s weekly average amount of articles?

Currently, no data Available

What is CCXI’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

VIVEViveve Medical

EOLSEvolus

LPTXLeap Therapeutics

NRSNNeurosense Therapeutics Ltd.

BCTBriaCell Therapeutics

Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing